U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07455448) titled 'Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study' on Feb. 19.
Brief Summary: This study aims to provide an updated analysis of the resistance patterns of H. pylori in the Nanjing region, with a focus on characterizing the current status of phenotypic and genotypic resistance to these six antimicrobial agents. The findings are expected to offer a scientific basis for the rapid diagnosis and personalized treatment of H. pylori infection.
Study Start Date: March, 2026
Study Type: OBSERVATIONAL
Condition:
HELICOBACTER PYLORI INFECTIONS
Intervention:
DIAGNOSTIC_TEST: Antimicrobial susceptibility test...